PLC Systems Receives FDA Permission to Begin RenalGuard(TM) Investigational Study (RedNova)
FRANKLIN, Mass., Oct. 24 /PRNewswire-FirstCall/ -- PLC Systems Inc. , a company focused on innovative cardiac and vascular medical device-based technologies, announced today that the U.S.

FDA To Expedite Reviews Of Some Generic Drugs, Official Says (Medical News Today)
FDA will accelerate reviews for certain generic medications, Steven Galson, director of the agency Center for Drug Evaluation and Research, said on Wednesday, Reuters/Los Angeles Times reports. According to Galson, FDA will accelerate reviews for the first generic versions of brand-name medications that no longer have patent or market exclusivity protection. [click link for full article]

Protein Polymer Technologies Receives FDA 510(k) Clearance of New Indication for Embolization Convenience Kits (SYS-CON Media)
Protein Polymer Technologies, Inc. (OTCBB: PPTI), a biotechnology device company that is a pioneer in protein designand synthesis, today announced that it has received 510(k) clearance fromthe U.S. Food and Drug Administration (FDA) to market its PVA foamembolization convenience kits for peripheral vascular indications includingtreatment of liver and renal tumors. The products were previously